OLD Category: lung disease

Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets

• Krushkal J, Silvers T, Reinhold WC...Evans D, Pommier Y, Teicher BA

Pulmonary Involvement in a Mouse Model of Sjögren’s Syndrome Induced by STING Activation

• Papinska J, Bagavant H, Gmyrek GB, Deshmukh US

E-cigarette-induced pulmonary inflammation and dysregulated repair are mediated by nAChR α7 receptor: role of nAChR α7 in SARS-CoV-2 Covid-19 ACE2 receptor regulation

• Wang Q, Sundar IK, Li D, Lucas JH, Muthumalage T, McDonough SR, Rahman I

Resolving Metabolic Heterogeneity in Experimental Models of the Tumor Microenvironment from a Stable Isotope Resolved Metabolomics Perspective

• Fan TW-M, Higashi RM, Chernayavskaya Y, Lane AN

Lung Function and Gene Expression of Pathogen Recognition Pathway Receptors: the Cardia Lung Study

• Ramasubramanian R, Kalhan R, Jacobs DR Jr, Washko GR, Hou L, Gross MD, Guan W, Thyagarajan B.

RELMα Is Induced in Airway Epithelial Cells by Oncostatin M without Requirement of STAT6 or IL-6 in Mouse Lungs In Vivo

• Ho L, Yip A, Lao F, Botelho F, Richards CD

Multicenter Evaluation of Independent High-Throughput and RT-qPCR Technologies for the Development of Analytical Workflows for Circulating miRNA Analysis

• Babayan A, Neumann MHD, Herdean A...Sprenger-Haussels M, Pantel K, Kloten V

Frequency of MET exon 14 skipping mutations in non-small cell lung cancer according to technical approach in routine diagnosis: results from a real-life cohort of 2,369 patients

• Champagnac A, Bringuier PP, Barritault M, Isaac S, Watkin E, Forest F, Maury JM, Girard N, Brevet M

Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient

• Rossi G, Russo A, Tagliamento M, Tuzi A, Nigro O, Vallome G, Sini C, Grassi M, Dal Bello MG, Coco S, Longo L, Zullo L, Tanda ET, Dellepiane C, Pronzato P, Genova C.

Biomarkers associated with beneficial PD-1 checkpoint blockade in non-small-cell lung cancer (NSCLC) identified using high-plex digital spatial profiling

• Zugazagoitia J, Gupta S, Liu Y, Fuhrman K, Gettinger S, Herbst RS, Schalper KA, Rimm DL.

Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase 2 trial

• Goldberg SB, Schalper KA, Gettinger SN...Wei W, Chiang V, Kluger HM

Comparison of GeneChip, nCounter and real-time polymerase chain reaction based gene expressions predicting loco-regional tumour control after primary and postoperative radiochemotherapy in head and neck squamous cell carcinoma

• Schmidt S et al.,